Expression of mos in astrocytic tumors and its potential role in neoplastic progression

Human Pathology

Volumn 33, Issue 7, 2002, Pages 703-707

  Perunovic, Branko ^a,b   Athanasiou, Athanasios ^a,b   Quilty, Robert D ^a,b   Gorgoulis, Vassilis G ^a,b   Kittas, Christos ^a,b   Love, Seth ^a,b  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Astrocytic neoplasms; Astrocytoma; Brain neoplasms; c mos gene; Immunohistochemistry; Lymphokines; p53; Proto onko gene proteins mos

Indexed keywords

GENE PRODUCT; LYMPHOKINE; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CANCER SURVIVAL; CELL CYCLE; CLINICAL FEATURE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MULTIMODALITY CANCER THERAPY; ONCOGENE; PROTO ONCOGENE;

EID: 0036650410     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.125377     Document Type: Article

References (35)

1. Astrocytic tumours
2. P85gag-mos encoded by ts 110 Moloney murine sarcoma virus has an associated protein kinase activity
3. Mos and the cell cycle
4. What does Mos do in oocytes and somatic cells?
5. Mos and the cell cycle: The molecular basis of the transformed phenotype
6. Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes
7. The c-mos gene product is required for cyclin B accumulation during meiosis of mouse eggs
8. The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs
9. The Mos/mitogen-activated protein kinase (MAPK) pathway regulates the size and degradation of the first polar body in maturing mouse oocytes
10. Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs
11. Parthenogenetic activation of oocytes in c-mos-deficient mice
12. C-mos proto-oncogene RNA transcripts in mouse tissues: Structural features, developmental regulation, and localization in specific cell types
13. Detection of c-mos proto-oncogene expression in human cells
14. Vimentin phosphorylation by p37mos protein kinase in vitro and generation of a 50-kDa cleavage product in v-mos-transformed cells
15. Ability of the c-mos product to associate with and phosphorylate tubulin
16. Evidence of an interaction between Mos and Hsp70: A role of the Mos residue serine 3 in mediating Hsp70 association
17. Phosphorylation of v-mos Ser 47 by the mitotic form of p34cdc2
18. pp39mos is associated with p34cdc2 kinase in c-mosxe-transformed NIH 3T3 cells
19. Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E 12 proteins
20. Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency
21. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p 53 function in transformation and chromosome instability
22. Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus
23. c-mos immunoreactivity is an indicator of good prognosis in lung cancer
24. Deregulated expression of c-mos in non-small cell lung carcinomas: Relationship with p53 status, genomic instability, and tumor kinetics
25. Incidence and timing of p 53 mutations during astrocytoma progression in patients with multiple biopsies
26. Structural alterations of the c-mos locus in benign pleomorphic adenomas with chromosome abnormalities of 8q12
27. No rearrangement of c-mos in salivary gland pleomorphic adenomas with 8q12 aberrations
28. Mos oncogene expression in human ovarian tumors
29. Abnormal expression of the MOS proto-oncogene in human thyroid medullary carcinoma
30. Mutation analysis of the c-mos proto-oncogene in human ovarian teratomas
31. Mos oncogene product associates with kinetochores in mammalian somatic cells and disrupts mitotic progression
32. Primate reproductive organs reveal a novel pattern of proto-oncogene c-mos and transcription factor Oct-3 mRNA expression
33. Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine/threonine kinase Mos
34. Cell cycle regulators in neuronal death evoked by excitotoxic stress: Implications for neurodegeneration and its treatment
35. Cell cycle-related gene expression in the adult rat brain: Selective induction of cyclin G1 and p21WAF1/CIP1 in neurons following focal cerebral ischemia